Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Black Diamond Therapeutics Inc increased its cash reserves by 60.76%, or 21.56m. Cash Flow from Financing totalled 71.93m or -- of revenues. In addition the company used 66.72m for operations while cash from investing totalled 16.35m.
Cash flow per share | -1.35 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.72 |
---|---|
Tangible book value per share | 1.72 |
More ▼
Balance sheet in USDView more
Current ratio | 5.55 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼